• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Linezolid-related immune-mediated severe thrombocytopenia.

作者信息

Pascoalinho Dulce, Vilas Maria João, Coelho Luís, Moreira Pedro

出版信息

Int J Antimicrob Agents. 2011 Jan;37(1):88-9. doi: 10.1016/j.ijantimicag.2010.10.001. Epub 2010 Nov 13.

DOI:10.1016/j.ijantimicag.2010.10.001
PMID:21075603
Abstract
摘要

相似文献

1
Linezolid-related immune-mediated severe thrombocytopenia.利奈唑胺相关的免疫介导的严重血小板减少症。
Int J Antimicrob Agents. 2011 Jan;37(1):88-9. doi: 10.1016/j.ijantimicag.2010.10.001. Epub 2010 Nov 13.
2
Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.回顾性队列图表回顾研究，分析与接受静脉注射利奈唑胺治疗的成年日本患者血小板减少症发展相关的因素。
Clin Ther. 2009 Oct;31(10):2126-33. doi: 10.1016/j.clinthera.2009.10.017.
3
Linezolid: low pre-treatment platelet values could increase the risk of thrombocytopenia.
J Antimicrob Chemother. 2005 Aug;56(2):440-1. doi: 10.1093/jac/dki202. Epub 2005 Jun 14.
4
Safety of linezolid in patients with baseline thrombocytopenia.
J Antimicrob Chemother. 2008 Oct;62(4):850-1. doi: 10.1093/jac/dkn285. Epub 2008 Jul 2.
5
A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin.比较退伍军人事务部接受利奈唑胺或万古霉素治疗的患者中不良血小板结局。
J Antimicrob Chemother. 2012 Mar;67(3):727-35. doi: 10.1093/jac/dkr522. Epub 2011 Dec 15.
6
Hematologic effects of linezolid in young children.利奈唑胺对幼儿的血液学影响。
Pediatr Infect Dis J. 2003 Sep;22(9 Suppl):S186-92. doi: 10.1097/01.inf.0000087021.20838.d9.
7
Tolerability of prolonged linezolid therapy in bone and joint infection: protective effect of rifampicin on the occurrence of anaemia?利奈唑胺治疗骨和关节感染的耐受性：利福平对贫血发生的保护作用？
J Antimicrob Chemother. 2010 Oct;65(10):2224-30. doi: 10.1093/jac/dkq281. Epub 2010 Jul 29.
8
Reduction of linezolid-associated thrombocytopenia by the dose adjustment based on the risk factors such as basal platelet count and body weight.基于基础血小板计数和体重等危险因素进行剂量调整以降低利奈唑胺相关性血小板减少症
Diagn Microbiol Infect Dis. 2014 May;79(1):93-7. doi: 10.1016/j.diagmicrobio.2014.01.012. Epub 2014 Jan 24.
9
Thrombocytopenia associated with linezolid therapy.与利奈唑胺治疗相关的血小板减少症。
Clin Infect Dis. 2002 Mar 1;34(5):695-8. doi: 10.1086/338403. Epub 2002 Jan 17.
10
Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study.长期使用利奈唑胺治疗慢性骨髓炎患者贫血的危险因素：一项病例对照研究。
J Antimicrob Chemother. 2004 Oct;54(4):798-802. doi: 10.1093/jac/dkh409. Epub 2004 Aug 25.

引用本文的文献

1
A nomogram incorporating linezolid and metabolite concentrations for predicting linezolid induced thrombocytopenia in patients with renal impairment.纳入利奈唑胺及其代谢物浓度的列线图预测肾功能损害患者利奈唑胺诱导的血小板减少症。
Sci Rep. 2024 Oct 30;14(1):26064. doi: 10.1038/s41598-024-77768-x.
2
Coagulation dysfunction events associated with echinocandins: a real-world study from FDA adverse event reporting system (FAERS) database.与棘白菌素相关的凝血功能障碍事件：一项来自美国食品药品监督管理局不良事件报告系统（FAERS）数据库的真实世界研究。
Thromb J. 2024 Aug 23;22(1):78. doi: 10.1186/s12959-024-00641-4.
3
Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database.
与利奈唑胺给药相关的药物不良事件：一项使用FAERS数据库的2004年至2023年真实世界药物警戒研究。
Front Pharmacol. 2024 Feb 16;15:1338902. doi: 10.3389/fphar.2024.1338902. eCollection 2024.
4
Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment.耐多药结核病治疗中利奈唑胺相关不良事件安全目标的推导及临床应用
Pharmaceuticals (Basel). 2023 Nov 8;16(11):1575. doi: 10.3390/ph16111575.
5
Linezolid vs Vancomycin in Induced Thrombocytopenia.利奈唑胺与万古霉素治疗药物性血小板减少症的比较
Infect Dis Ther. 2022 Aug;11(4):1649-1660. doi: 10.1007/s40121-022-00663-3. Epub 2022 Jun 21.
6
Development and validation of a risk prediction model for linezolid-induced thrombocytopenia in elderly patients.开发和验证老年患者利奈唑胺诱导血小板减少症的风险预测模型。
Eur J Hosp Pharm. 2024 Feb 22;31(2):94-100. doi: 10.1136/ejhpharm-2022-003258.
7
Effect of renal function on the risk of thrombocytopaenia in patients receiving linezolid therapy: A systematic review and meta-analysis.肾功能对利奈唑胺治疗患者血小板减少症风险的影响：系统评价和荟萃分析。
Br J Clin Pharmacol. 2022 Feb;88(2):464-475. doi: 10.1111/bcp.14965. Epub 2021 Oct 10.
8
Linezolid Inhibited Synthesis of ATP in Mitochondria: Based on GC-MS Metabolomics and HPLC Method.利奈唑胺抑制线粒体中 ATP 的合成：基于 GC-MS 代谢组学和 HPLC 方法。
Biomed Res Int. 2018 Oct 16;2018:3128270. doi: 10.1155/2018/3128270. eCollection 2018.
9
Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients.住院患者中利奈唑胺诱导血小板减少症的群体药代动力学和药效学
Br J Clin Pharmacol. 2017 Aug;83(8):1758-1772. doi: 10.1111/bcp.13262. Epub 2017 Mar 31.
10
Thrombocytopenia in Patients Receiving Prolonged Linezolid May be Caused by Oxidative Stress.接受长期利奈唑胺治疗的患者出现血小板减少可能是由氧化应激引起的。
Clin Drug Investig. 2016 Jan;36(1):67-75. doi: 10.1007/s40261-015-0352-0.